Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat

Brain Research

Volumn 812, Issue 1-2, 1998, Pages 216-226

  Uchino, Hiroyuki ^a   Elmér, Eskil ^b   Uchino, Keiko ^a   Li, Ping An ^b   He, Qing Ping ^b   Smith, Maj Lis ^c   Siesjö, Bo K ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b The Queen's Neuroscience Institute   (United States)

^c Div Exp Brain Res Wallenberg N ^*  (Sweden)

Author keywords

Calcineurin; Cyclosporin A; Ischemia; Mitochondria; Mitochondrial permeability transition; Neuroprotection

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 2; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INJURY; BRAIN ISCHEMIA; GENE EXPRESSION; HISTOPATHOLOGY; MEMBRANE PERMEABILITY; NERVE CELL LESION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD-BRAIN BARRIER; CYCLOSPORINE; IMMUNOSUPPRESSIVE AGENTS; ISCHEMIC ATTACK, TRANSIENT; NEUROPROTECTIVE AGENTS; PROSENCEPHALON; RATS; TREATMENT OUTCOME;

EID: 0032561733     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00902-0     Document Type: Article

References (65)

1. Auer R.N., Wieloch T., Olsson Y., Siesjö B.K. The distribution of hypoglycemic brain damage. Acta Neuropathol. 64:1984;177-191.
2. 3H -cyclosporine A in mice Pharmacol. Toxicol. 62:1988;110-117.
3. Begley D.J., Squires L.K., Zlokovic B.V., Mitrovic D.M., Hughes C.C., Revest P.A., Greenwood J. Permeability of the blood brain barrier to the immunosuppressive cyclic peptide cyclosporin A. J. Neurochem. 55:1990;1222-1230.
4. Bernardi P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J. Biol. Chem. 267:1992;8834-8839.
5. Bernardi P. The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim. Biophys. Acta. 1275:1996;5-9.
6. Bram R.J., Hung D.T., Martin P.K., Schreiber S.L., Crabtree G.R. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol. Cell Biol. 13:1993;4760-4769.
7. Broekemeier K., Pfeiffer D. Inhibition of the mitochondrial permeability transition by cyclosporin A during long time frame experiments: relationship between pore opening and the activity of mitochondrial phospholipases. Biochemistry. 34:1995;16440-16449.
8. Buchan A.M., Li H., Cho S., Pulsinelli W.A. Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neurosci. Lett. 132:1991;255-258.
9. 2+-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia. J. Cereb. Blood Flow Metab. 14:1994;903-910.
10. Butcher S.P., Henshall D.C., Teramura Y., Iwasaki K., Sharkey J. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J. Neurosci. 17:1997;6939-6946.
11. Cefalu W., Pardrige W. Restrictive transport of lipid-soluble peptide (cyclosporin) through the blood-brain barrier. J. Neurochem. 45:1985;1954-1956.
12. Clipstone N.A., Crabtree G.R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature. 357:1992;695-697.
13. Costantini P., Chernyak B.V., Petronilli V., Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 271:1996;6746-6751.
14. Crompton M., Andreeva L. On the involvement of a mitochondrial pore in reperfusion injury. Basic Res. Cardiol. 88:1993;513-523.
15. 2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J. 255:1988;357-360.
16. Deshpande J.K., Siesjö B.K., Wieloch T. Calcium accumulation and neuronal damage in the rat hippocampus following cerebral ischemia. J. Cereb. Blood Flow Metab. 7:1987;89-95.
17. Diemer N.H., Johansen F.F., Jörgensen M.B. N-methyl-D-aspartate and non-N-methyl-D-aspartate antagonists in global cerebral ischemia. Stroke. 21:1990;39-42. Suppl. III.
18. Dienel G.A. Regional accumulation of calcium in postischemic rat brain. J. Neurochem. 43:1984;913-925.
19. Duchen M.R., McGuinness O., Brown L.A., Crompton M. On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc. Res. 27:1993;1790-1794.
20. Dux E., Mies G., Hossmann K.-A., Siklós L. Calcium in the mitochondria following brief ischemia of gerbil brain. Neurosci. Lett. 78:1987;295-300.
21. Ellis C.N., Fradin M.S., Hamilton T.A., Voorhees J.J. Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy. Arch. Dermatol. 131:1995;791-795.
22. Erlanger B.F. Do we know the site of action of cyclosporin? Immunol. Today. 13:1992;487-490.
23. 2+ plus prooxidants. J. Biol. Chem. 265:1990;19955-19960.
24. Gogvadze V., Richter C. Cyclosporine A protects mitochondria in an in vitro model of hypoxia/reperfusion injury. Fed. Eur. Biochem. Soc. Lett. 333:1993;334-338.
25. Gunter T.E., Gunter K.K., Sheu S.S., Gavin C.E. Mitochondrial calcium transport: physiological and pathological relevance. Am. J. Physiol. 267:1994;C313-C339.
26. Gunter T.E., Pfeiffer D.R. Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 258:1990;C755-C786.
27. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J., Speicher D.W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science. 226:1984;544-547.
28. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:1982;57-69.
29. 2+ acting at the external side of the inner mitochondrial membrane can stimulate mitochondrial permeability transition induced by phenylarsine oxide. Biochim. Biophys. Acta. 1322:1997;221-229.
30. 2+ ions. A proposed model for phosphate-stimulated lipid peroxidation. J. Biol. Chem. 271:1996;2929-2934.
31. Kristal B.S., Park B.K., Yu B.P. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J. Biol. Chem. 271:1996;6033-6035.
32. 2+ release from mitochondria by the oxidation-reduction state of pyridine nucleotides. Proc. Natl. Acad. Sci. USA. 75:1978;1690-1694.
33. Liu J. FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. Trends Pharmacol. Sci. 14:1993;182-188.
34. Morris P.J. Cyclosporine, FK506 and other drugs in organ transplantation. Curr. Opin. Immunol. 3:1991;748-751.
35. Nellgård B., Wieloch T. Postischemic blockade of AMPA but no NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J. Cereb. Blood Flow Metab. 12:1992;2-11.
36. Novgorodov S.A., Gudz T.I., Milgrom Y.M., Brierley G.P. The permeability transition in heart mitochondria is regulated synergistically by ADP and cyclosporin A. J. Biol. Chem. 267:1992;16274-16282.
37. O'Keefe S.J., Tamura J., Kincaid R.L., Tocci M.J., O'Neill E.A. FK506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature. 357:1992;692-694.
38. Ogawa N., Tanaka K., Kondo Y., Asanuma M., Mizukawa K., Mori A. The preventive effect of cyclosporin A, an immunosuppressant, on the late onset reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia. Neurosci. Lett. 152:1993;173-176.
39. Packer M.A., Murphy M.P. Peroxynitrite formed by simultaneous nitric oxide and superoxide generation causes cyclosporin A-sensitive mitochondrial calcium efflux and depolarisation. Eur. J. Biochem. 234:1995;231-239.
40. Pahlmark K., Folbergrová J., Smith M.-L., Siesjö B.K. Effects of dimethylthiourea on selective neuronal vulnerability in forebrain ischemia in rats. Stroke. 24:1993;731-737.
41. Palestine A., Nussenblatt R., Chan C. Block receptors for HLA-DR antigens on T cells. Nature. 290:1981;792-794.
42. G. Paxinos, C. Watson, The rat brain in stereotaxic coordinates, 3rd compact edn., Academic Press, San Diego, 1997.
43. W. Pulsinelli, M. Jacewicz, A. Buchan, Antagonists of excitatory amino acid neurotransmitters: a comparison of their effects on global vs. focal ischemia, Drug Research related to neuroactive amino acids, Munksgaard, Copenhagen, 1992.
44. 2+: their relationship to apoptosis and oncogenesis. Fed. Eur. Biochem. Soc. Lett. 325:1993;104-107.
45. Richter C., Gogvadze V., Laffranchi R., Schlapbach R., Schweizer M., Suter M., Walter P., Yaffee M. Oxidants in mitochondria: from physiology to diseases. Biochim. Biophys. Acta. 1271:1995;67-74.
46. Ryffel B. Pharmacology of cyclosporine: VI. Cellular activation: regulation of intracellular events by cyclosporine. Pharmacol. Rev. 41:1990;407-422.
47. Sakata A., Tamai I., Kawazu K., Deguchi Y., Ohnishi T., Saheki A., Tsuji A. In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. Biochem. Pharmacol. 48:1994;1989-1992.
48. Schreiber S.L., Crabtree G.R. The mechanism of action of cyclosporin A and FK506. Immunol. Today. 13:1992;136-142.
49. Sharkey J., Butcher S.P. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischemia. Nature. 371:1994;336-339.
50. Shiga Y., Onodera H., Matsuo Y., Kogure K. Cyclosporin A protects against ischemia-reperfusion injury in the brain. Brain Res. 595:1992;145-148.
51. B.K. Siesjö, T. Kristián, K. Katsura, The role of calcium in delayed postischemic brain damage, in: Moskowitz, L.R.M. Caplan (Eds.), Cerebrovascular Diseases, 19th Princeton Stroke Conference, Butterworth-Heinemann, Boston, 1995, pp. 353-370.
52. Sigal N.H., Dumont F.J. Cyclosporin A, FK506 and rapamycin: pharmacological probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10:1992;519-560.
53. +] in the hippocampus during recovery from short-term, transient ischemia. J. Cereb. Blood Flow Metab. 12:1992;759-772.
54. Sims N.R., Pulsinelli W.A. Altered mitochondrial respiration in selectively vulnerable brain subregions following transient forebrain ischemia in the rat. J. Neurochem. 49:1987;1367-1374.
55. Smith M.-L., Auer R.N., Siesjö B.K. The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol. 64:1984;319-332.
56. Smith M.-L., Kalimo H., Warner D.S., Siesjö B.K. Morphological lesions in the brain preceding the development of postischemic seizures. Acta Neuropathol. 76:1988;253-264.
57. M.-L. Smith, B.K. Siesjö, Postischemic treatment with the ω-conopeptide SNX111 protects the rat brain against ischemic damage, in: J. Krieglstein, H. Oberpilcher (Eds.), Pharmacology of Cerebral Ischemia, Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1992, pp. 161-167.
58. Tokime T., Nozaki K., Kikuchi H. Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil. Neurosci. Lett. 206:1996;81-84.
59. Tsuji A., Tamai I., Sakata A., Tenda Y., Terasaki T. Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter P-glycoprotein. Biochem. Pharmacol. 46:1993;1096-1099.
60. Uchino H., Elmér E., Uchino K., Lindvall O., Siesjö B.K. Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat. Acta Physiol. Scand. 155:1995;469-471.
61. Valentino K., Newcomb R., Gadbois T., Singh T., Bowersox S., Bitner S., Justice A., Yamashiro D., Hoffman B.B., Ciaranello R., Miljanich G., Ramachandran J. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc. Natl. Acad. Sci. USA. 90:1993;7894-7897.
62. Vercesi A.E., Kowaltowski A.J., Grijalba M.T., Meinicke A.R., Castilho R.F. The role of reactive oxygen species in mitochondrial permeability transition. Biosci. Rep. 17:1997;43-52.
63. Zaidan E., Sims N.R. The calcium content of mitochondria from brain subregions following short-term forebrain ischemia and recirculation in the rat. J. Neurochem. 63:1994;1812-1819.
64. Zamzami N., Hirsch T., Dallaporta B., Petit P.X., Kroemer G. Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J. Bioenerg. Biomembr. 29:1997;185-193.
65. Zoratti M., Szabo I. The mitochondrial permeability transition. Biochim. Biophys. Acta. 1241:1995;139-176.